Medidata acquires SHYFT: Powering the Digital Transformation for Life Sciences

Comments
Medidata to acquire SHYFT Analytics bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.

Digital transformation: this is one of the hottest topics in our industry today, creating both opportunities and challenges for our customers. For pharmaceutical, biotech, and medical device companies, the promise of making data-driven, insights-led decisions in real-time means getting the right treatments to the right patients at the right time. To truly realize this potential, they need to rely on combined insights from both clinical and commercial data.

That’s why I’m so excited about our announcement today that we’ve entered into an agreement to acquire SHYFT Analytics. Combining SHYFT with Medidata brings the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.

Medidata and SHYFT now have an unprecedented ability to manage and optimize value across the clinical and commercial continuum. Customers can power their digital transformation with artificial intelligence and real world analytics, reducing risk, optimizing revenue and ultimately helping patients.

I look forward to discussing this new area for life sciences with industry leaders.

Check out the video below and learn more at https://www.mdsol.com/en/shyft/learn-more.

About Author

Tarek Sherif

Medidata Chairman & CEO

A founder of Medidata Solutions, Tarek has served as CEO since 2001 and chairman since 2009. Including Medidata’s successful public offering in 2009, Tarek has led Medidata from startup to becoming the leading global provider of cloud-based solutions to the life science industry and one of the largest public technology companies founded in New York City.  Medidata is the global leader in collecting and managing clinical trial data and supports trials in more than 120 countries, while defining the vertical cloud company business model. Medidata’s mission is to power smarter treatments and healthier people.

Tarek has more than 30 years of leadership experience in health-tech and finance. Prior to Medidata, he co-managed and managed equity funds focused on public and private technology and life sciences companies, as well as holding various positions in finance.

Tarek received his BA in economics from Yale University in 1984 and graduated from Columbia Business School in 1991, where he earned a degree in business administration and finance. He serves as the co-chair of the Partnership Fund for New York City, which is focused on creating business opportunities and jobs for city residents. Tarek also sits on the advisory board of Students on Ice, a not-for-profit organization focused on inspiring youth through educational expeditions to the polar regions,​ the Musculoskeletal Advisory Board at NYU Langone Medical Center​, ​and Defy Ventures—a New York-based non-profit dedicated to​ providing business leadership ​training ​and entrepreneurial ​education to​ people with criminal histories.